Venus Medtech Lock-Up Expiry: Could Face Selling Pressure
Venus Medtech is a dominant player in the heart valve replacement (TAVR) market in China and was listed in Hong Kong on December 10th. Since...
418 Views
Kangji Medical (康基医疗) Pre-IPO: COVID-19 Impacts and Thoughts on Valuation
Kangji Medical is a domestic leader in minimally invasive surgery devices. It has three main product types, trocars, polymer ligation clips, and...
519 Views
Peijia Medical IPO: Trading Debut Equals First-Day Pop?
Peijia Medical (9996 HK) is a leading transcatheter heart valve medical device company in China. Peijia will commence trading on Friday, 15 May. At...
307 Views
Peijia Medical (沛嘉医疗) IPO Trading: Action for the High Flyer
Peijia Medical raised HKD 2.2 billion (USD 283 m) from its global offering and will list on the stock exchange tomorrow. In our previous insight,...
350 Views
Peijia Medical IPO: Valuation Insights
Peijia Medical (9996 HK) is a leading transcatheter heart valve medical device company in China. Peijiahas launched a Hong Kong IPO to raise net...
384 Views